Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 3Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Respiratory Tract Diseases 1Papillary renal cell carcinoma, sporadic 1Pancreatic Intraductal Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Squamous Cell 1Neoplasms, Basal Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1Liver Cirrhosis 1Leiomyosarcoma 1Laryngeal Neoplasms 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Histiocytoma, Malignant Fibrous 1Hereditary leiomyomatosis and renal cell cancer 1

Interventions

pembrolizumab 5Nivolumab 3Cisplatin 3Taxes 2Paclitaxel 2poly ICLC 1fludarabine phosphate 1fludarabine 1abemaciclib 1Risk Factors 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Pemetrexed 1Nimorazole 1Injections 1High-Intensity Focused Ultrasound Ablation 1Erlotinib Hydrochloride 1Docetaxel 1Cyclophosphamide 1Cetuximab 1Carboplatin 1Biological Products 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Squamous Cell × Erlotinib Hydrochloride × 1 year × Clear all
NCT00076310 2026-04-15

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled 11 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡